Paragon 28FNA
About: Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of revenue from the United States.
Employees: 525
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
869% more call options, than puts
Call options by funds: $126K | Put options by funds: $13K
107% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 15
46% more capital invested
Capital invested by funds: $335M [Q3] → $491M (+$156M) [Q4]
14% more funds holding
Funds holding: 112 [Q3] → 128 (+16) [Q4]
3% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 38
0% more funds holding in top 10
Funds holding in top 10: 5 [Q3] → 5 (+0) [Q4]
4.47% less ownership
Funds ownership: 61.26% [Q3] → 56.79% (-4.47%) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Stephens & Co. Mason Carrico 12% 1-year accuracy 3 / 26 met price target | $13 | Equal-Weight Downgraded | 30 Jan 2025 |
Needham Mike Matson 22% 1-year accuracy 27 / 121 met price target | $13 | Hold Downgraded | 29 Jan 2025 |
Financial journalist opinion
Based on 16 articles about FNA published over the past 30 days









